The sold production of diagnostic reagents and other pharmaceutical preparations in France has experienced fluctuating trends over the past decade. After substantial growth in 2016 and 2017, the industry faced volatility, with significant declines in some years. The actual production value in 2023 stood at 711.11 million Euros, showing a 1.63% drop from 2022. Despite minor recoveries, the overall trend since 2021 points to a gradual decline. The CAGR over the last five years was -1.34%, indicating a slow but steady decrease in production volumes. Forecasts suggest this downward trend will continue, with a projected reduction of 6.51% over the next five years.

Future trends to watch for include:

Impact of technological advancements in diagnostics and their potential to revitalize the market.
Regulatory changes and their effects on production and market entry.
Global economic conditions and their influence on pharmaceutical investment and production capabilities in France.
Emerging diseases and increased focus on healthcare spending.